Category:
Protein/Antigen/Polypeptide
CAS NO:
N/A
Standard:
ChP,
To be launched in 2025
New Options for Growth Treatment
Low dose, low AE.
Stable structure, high bioactivity
Aimed at reducing dose & pursuing long-termtreatment efficacy and safety
Patented in many countries